SEC Comment Letter for Rezolute, Inc. (RZLT) (CIK 0001509261) (RZLT) — Dec 22, 2016
Rezolute, Inc. (RZLT) (CIK 0001509261)
Date: Dec. 22, 2016 · CIK: 0001509261 · Accession: 0000000000-16-106302
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-214974
Letter
Mail Stop 4546 December 22, 2016 Nevan Elam Chief Executive Officer AntriaBio, Inc. 1450 Infinite Drive Louisville, CO 80027
Re: AntriaBio, Inc. Registration Statement on Form S-1 Filed December 8 , 2016 File No. 333-214974
Dear Mr. Elam :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at (202) 551 -2544 with any questions.
Sincerely,
/s/ Joseph McCann for
Show Raw Text
Mail Stop 4546 December 22, 2016 Nevan Elam Chief Executive Officer AntriaBio, Inc. 1450 Infinite Drive Louisville, CO 80027 Re: AntriaBio, Inc. Registration Statement on Form S-1 Filed December 8 , 2016 File No. 333-214974 Dear Mr. Elam : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at (202) 551 -2544 with any questions. Sincerely, /s/ Joseph McCann for Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Michael L. Weiner , Esq. Dorsey & Whitney LLP